Zeskind Benjamin J. 4
4 · Immuneering Corp · Filed Jul 3, 2025
Insider Transaction Report
Form 4
Immuneering CorpIMRX
Zeskind Benjamin J.
DirectorPRESIDENT AND CEO
Transactions
- Purchase
Class A Common Stock
2025-07-01$3.38/sh+2,985$10,087→ 2,305,837 total - Purchase
Class A Common Stock
2025-07-02$3.53/sh+7,015$24,792→ 2,312,852 total
Holdings
- 894,927(indirect: See Foonote)
Class A Common Stock
Footnotes (3)
- [F1]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $3.35 to $3.41. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price.
- [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $3.45 to $3.64. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price.
- [F3]Held by the Benjamin J. Zeskind 2020 Family Trust, where Lisa Schwartz, Dr. Zeskind's spouse, serves as sole trustee.